Long-Term Outcomes of Transcatheter Aortic Valve Replacement 

The Placement of Aortic Transcatheter Valves (PARTNER) trial demonstrated that transcatheter aortic valve replacement (TAVR) for high-risk patients with aortic stenosis resulted in similar outcomes at 1, 2 and 3 years compared with surgical aortic valve replacement (SAVR). The present study reports the 5-year outcomes of this trial. The study enrolled 699 patients who were […]

Read More…

Clinical Outcomes at 1 Year Following Transcatheter Aortic Valve Replacement  

To date, long-term outcome data following transcatheter aortic valve replacement (TAVR) has only been available from clinical trial data.  Evaluating long-term outcomes of TAVR in real-world use is important to ensure the anticipated benefits are observed in routine clinical practice.  Using data from the Society of Thoracic Surgeons/American College of Cardiology (STS/ACC) Transcatheter Valve therapies […]

Read More…

Bicuspid aortic valves – increased morbidity but not mortality

Bicuspid aortic valve is the commonest congenital cardiac abnormality in the adult population.  Previous pathological studies have outlined aortic valve dysfunction, endocarditis, and even aortic dissection as potential causes of increased morbidity in this patient group.  The purpose of this study was to observe the disease progression and cardiac outcomes of a large contemporary adult […]

Read More…